WINQ Eyelid Serum: The Clinically-Proven Solution for Digital Eye Strain Subtitle
A Solution to Screen-Induced Dry Eye:
This unique serum targets the root cause of screen-induced discomfort by restoring the natural blink mechanism, directly supporting tear film health, and offering rapid relief in a single, dual-action product.
Targeting the Cause of Screen Fatigue
The WINQ Eyelid Serum is an innovative, evidence-based therapy. It uses gentle cooling plant extracts to target the TRPM8 cold receptors in the periocular area, which naturally activates and increases the patient’s subconscious blink rate. This action helps to constantly refresh the tear film, reduce evaporation, and alleviate eye fatigue.
Key Features of WINQ
Clinically Proven
A Randomised Controlled Trial (RCT) showed a significant 27% increase in blink rate and a 50% reduction in partial blink rate post-application.
Dual-Action Therapy
Combines essential eye health benefits (blink activation, hydration) with premium skincare ingredients, increasing patient appeal
Key Ingredients
Contains Hyaluronic Acid (HA) for superior hydration and lubrication, alongside Caffeine and Niacinamide to visibly reduce puffiness and dark circles.
Interested in using Lash Builder in your practice?
Contact us to find out more about Lash Builder and to order.
References:
1. Mertzanis P, Venkataraman K, Begley C, Chalmers R, Abetz L. The Impact of Dry Eye on Daily Life: Results from a Qualitative Study. Investigative
Ophthalmology & Visual Science December 2002, Vol.43, 74.
2. Kitazawa M, Sakamoto C, Yoshimura M, Kawashima M, Inoue S, Mimura M, Tsubota K, Negishi K, Kishimoto T. The Relationship of Dry Eye Disease with
Depression and Anxiety: A Naturalistic Observational Study. Transl Vis Sci Technol. 2018 Dec 28;7(6):35. doi: 10.1167/tvst.7.6.35. PMID: 30619655; PMCID: PMC6314109.
3. Sarkar J, Chaudhary S, Namavari A, Ozturk O, Chang JH, Yco L, Sonawane S, Khanolkar V, Hallak J, Jain S. Corneal neurotoxicity due to topical benzalkonium chloride. Invest Ophthalmol Vis Sci. 2012 Apr 6;53(4):1792-802. doi: 10.1167/iovs.11-8775. PMID: 22410563; PMCID: PMC3995561.
4. Sarkar J, Chaudhary S, Namavari A, Ozturk O, Chang JH, Yco L, Sonawane S, Khanolkar V, Hallak J, Jain S. Corneal neurotoxicity due to topical benzalkonium chloride. Invest Ophthalmol Vis Sci. 2012 Apr 6;53(4):1792-802. doi: 10.1167/iovs.11-8775. PMID: 22410563; PMCID: PMC3995561.
Read the news on
Positive Impact
Dry Eye January: Empower your patients to take control of their eye health. Learn how to educate and engage your patients about the importance of early diagnosis and treatment for dry eye.
Positive Impact, in partnership with Visioneering Technologies, Inc. (VTI), has won The Contact Lens Award at the prestigious Optician Awards 2024 for its NaturalVue® Enhanced Multifocal 1 Day contact lens.
Join Nick Atkins in this CPD webinar as he explores effective heat delivery options for managing MGD. Gain insights into both in-practice and at-home solutions to enhance your practice’s MGD management strategies.